Ventas, Inc.
Ventas, Inc.
Your view on VTR
Overview
What the company does, where it operates, and who runs it.
About Ventas, Inc.
- Industry
- REIT - Healthcare Facilities
- Sector
- Real Estate
- CEO
- Debra A. Cafaro
- Headquarters
- 353 North Clark Street, Chicago, IL, US
- Industry
- REIT - Healthcare Facilities
- Sector
- Real Estate
- CEO
- Debra A. Cafaro
- Headquarters
- 353 North Clark Street, Chicago, IL, US
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate.
As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population.
For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders.
As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Ventas, Inc., and the rating behind it. VTR last traded at $87.42, 158.7× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Ventas, Inc.. Starting points for Ventas, Inc.: P/E 158.7, EPS $0.55, beta 0.74 — an REIT - Healthcare Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Ventas, Inc.. Ventas, Inc. paid $2.04 per share over the last year — a 2.3% yield at the current $87.42 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Ventas, Inc.. Trailing twelve-month EPS for Ventas, Inc. stands at $0.55. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Ventas, Inc.. Ventas, Inc. has reported as a listed company since 1997. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Ventas, Inc. valued side by side against its closest peers. Ventas, Inc. is measured against REIT - Healthcare Facilities peers within the Real Estate sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Ventas, Inc., and how their positions are changing. At a $44.84B market value, institutional positions materially move Ventas, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Ventas, Inc. executives and directors. Shares of Ventas, Inc. have traded between $56.68 and $80.29 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Ventas, Inc.. Ventas, Inc. is a $44.84B Real Estate company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Ventas, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Ventas, Inc.. Coverage tracks Ventas, Inc. within REIT - Healthcare Facilities (Real Estate). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.